Reviewed by Dr. Ankeet Choxi and Jarred Mait, MD
Regenerative medicine marketing often centers on the lab: certifications, processing claims, proprietary formulas. But for patients seeking Dezawa Muse stem cell therapy, the most consequential variable is the physician’s procedural experience – not the label on the vial. Drs. Ankeet Choxi and Jarred Mait of STEMS Health explain why clinical volume and physician judgment consistently outperform lab-centric marketing as predictors of patient outcomes.
What Lab Marketing Looks Like – and Why It Resonates
The regenerative medicine space is crowded, and differentiation is difficult. As a result, many providers and product companies compete on credentials that are easy to communicate: GMP-certified facilities, ISO standards, proprietary extraction methods, exclusive cell populations. These claims are not necessarily false – but they are rarely the determining factor in whether a patient improves.
Patients respond to lab marketing because it feels objective. Numbers and certifications seem more verifiable than physician skill. But a certified lab cannot diagnose a patient. It cannot guide an injection under ultrasound. It cannot assess whether a presentation warrants treatment at all, or adjust a protocol when a patient’s response signals a need for modification.
Those decisions belong to the physician – and they require experience.
What Procedural Experience Actually Means
Volume Creates Pattern Recognition
Physicians who have administered Muse cell protocols across a broad range of patient profiles develop pattern recognition that cannot be obtained from a training course or a product brochure. They recognize which presentations respond robustly, which require protocol adjustment, and which should not be treated at all.
At STEMS Health, Drs. Choxi and Mait have developed this recognition across a wide variety of musculoskeletal, neurological, and systemic conditions. That accumulated clinical knowledge shapes every treatment decision – from the initial diagnosis to the post-procedure follow-up protocol.
Experience Informs Injection Technique
The precision of regenerative injection is a procedural skill. It requires familiarity with anatomy, comfort with imaging guidance technology, and the practiced judgment to adapt when tissue architecture varies from the textbook expectation. These capabilities are acquired through volume and reinforced by outcome tracking – not lab credentials.
A physician performing their fifth Muse cell injection is in a fundamentally different position than one performing their five-hundredth. That gap is clinically meaningful, and patients deserve to understand it.
The Risks of Prioritizing Lab Over Physician
When patients choose a provider primarily because of lab marketing, several risks emerge:
- Inadequate pre-treatment evaluation: Labs provide products, not diagnoses. A provider who relies heavily on the lab’s reputation may underinvest in the clinical evaluation that determines whether treatment is appropriate.
- Generic protocols: Providers with limited procedural experience tend to apply standardized protocols that do not account for individual patient variability in inflammation status, tissue quality, or anatomical complexity.
- Poor outcome tracking: Experienced physicians know what follow-up to conduct and what changes to look for. Without that framework, both successes and failures go unmeasured – and learning does not occur.
Questions That Reveal Physician Experience
When evaluating a provider for Dezawa Muse stem cell therapy, patients should ask questions that illuminate experience – not lab credentials:
- How many Muse cell procedures has this physician performed, and for which conditions?
- What is the pre-treatment evaluation protocol, and how does diagnosis inform the protocol design?
- How is injection guidance performed, and what imaging technology is used?
- What does post-procedure follow-up look like, and how are outcomes tracked over time?
A physician with genuine procedural experience will answer these questions specifically. Vague responses that redirect to lab quality are a meaningful signal.
The STEMS Health Approach to Continuous Improvement
At STEMS Health, Drs. Choxi and Mait operate within a framework of outcome-informed practice. Each patient’s progress is tracked, and findings inform protocol refinement across the patient population. This is not research in the formal sense – it is the applied learning that separates an evolving clinical practice from a static product administration service.
Patients treated at STEMS Health benefit not only from individual clinical judgment, but from the cumulative knowledge that experience and outcome tracking produce over time. That knowledge lives with the physician – and it is the most important differentiator in regenerative medicine.
Frequently Asked Questions
Q: How do I evaluate a physician’s experience with Muse cell therapy?
Ask directly about procedural volume, the range of conditions treated, and what outcome tracking is in place. Also ask whether the physician has continued education in regenerative protocols and whether they collaborate with other specialists. A physician invested in outcomes will be transparent and specific in their answers.
Q: Does the source of the Muse cell preparation matter?
Yes – sourcing and processing standards affect viability and potency. But these are threshold requirements, not differentiators at the level that determines outcomes. Once a preparation meets clinical quality standards, the physician’s diagnostic and procedural skill becomes the dominant variable.
Q: Are there certifications or credentials I should look for in a regenerative medicine physician?
Board certification in relevant specialties (orthopedics, physical medicine and rehabilitation, neurology, internal medicine) provides a foundation. Training in musculoskeletal ultrasound and interventional procedures is particularly relevant for injection-based therapies. Membership in regenerative medicine professional organizations can also indicate continuing engagement with evolving standards.
Q: What is the difference between a physician who administers Muse cells and one who has experience with them?
Administration is mechanical – receiving the product and delivering it. Experience means having navigated the full clinical arc: diagnosing appropriately, designing protocols around individual patient variables, managing unexpected responses, and tracking outcomes over time. That experience shapes every aspect of the patient encounter – not just the injection itself.
Disclosure
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs.Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration.Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment.© STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.
